Evonetix
evonetix.com
Actively hiring
Web Hosting & VPS
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$24M
1 round on record
Latest round
$24M
Venture round · Feb 2023 · 3 yr ago
Backers
2
DCVC, Foresite Capital
The money's age
Long since its last round
43 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 7, 2023
Raised a round Venture round $24M · NewsMedical
Jun 13, 2022
New executive Evonetix Appoints Colin McCracken as Chief Executive Officer · FinanzNachrichten.de
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2023 | $24M | — | NewsMedical |
Backed byfrom the funds' portfolios and accelerator catalogs
DCVC 
Foresite Capital News
Evonetix, imec Partner on Chip-Based Technology Scale-Up Pharmaceutical Technology
The partners will collaborate on developing scale-up chip-based technology to enable commercial-scale production of a third-generation DNA synthesis platform.
Read more
Report
Evonetix Receives Patent for Thermally-Controlled DNA Synthesis Technology Pharmaceutical Technology
Evonetix's thermally controlled DNA synthesis technology is designed to enable highly parallel DNA synthesis in a benchtop platform.
Read more
Report
Evonetix delivers first chip-synthesized DNA to the University of Cambridge
Evonetix, the company bringing semiconductor technology to DNA synthesis, today announced that DNA synthesized using its unique semiconductor chip technology was delivered to the Department of Chemical Engineering and Biotechnology at the University of Ca
Read more
Report
Evonetix closes $24 million USD (£20 million) financing
Funding will enable development of DNA synthesis chip technology to commercial scale.
Read more
Report
Evonetix Appoints Colin McCracken as Chief Executive Officer
EVONETIX LTD ('Evonetix'), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate
Read more
Report
Evonetix Demonstrates Novel Enzymatic DNA Synthesis Method
Proprietary thermally-controlled synthesis chemistry will enable production of high quality DNA at scale Key milestone in development of Evonetix's benchtop DNA synthesis platform EVONETIX
Read more
Report
Financials
Total raised
$24M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2023 | $24M | Details |